Clinical Trial Update: Efficacy of Fexuprazan for Prevention or Control of Gastritis Symptoms in Patients on Treatment With Systemic Steroids [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update evaluates the efficacy of fexuprazan to prevent or control gastritis symptoms in patients on systemic steroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• Fexuprazan (fexuprazan)

Snippet

Sponsor: Yonsei University | Conditions: Patients on Treatment With Systemic Steroids | Phase 4 | Status: COMPLETED